MétaCan
Menu
Retour à la cohorte
Enregistrement W4412527279 · doi:10.3322/caac.70025

Dr Harmon Eyre, MD (1941–2025)

2025· article· en· W4412527279 sur OpenAlexaboutno aff
John R. Seffrin, Otis W. Brawley

Notice bibliographique

RevueCA A Cancer Journal for Clinicians · 2025
Typearticle
Langueen
DomaineArts and Humanities
ThématiqueMedical History and Innovations
Établissements canadiensnon disponible
Organismes subventionnairesnon disponible
Mots-clésMedicine

Résumé

récupéré en direct d'OpenAlex

Dr Harmon Eyre, a much-respected figure of the American Cancer Society (ACS), passed away on May 31, 2025, in Salt Lake City. He was 84 years old. Dr Eyre started with the ACS as a volunteer in 1971 and joined the ACS national board in 1978. He became its national volunteer president in 1988 and, from 1993 to 2008, served as the Chief Medical Officer and the Editor-in-Chief of CA: A Cancer Journal for Clinicians. During his tenure, he increased the effectiveness of the ACS by elevating an emphasis on cancer control and the recruitment of world-class scientists into this ACS research program. In time, it would become one of the leading cancer epidemiology and surveillance groups worldwide. These nascent efforts would bring about one of the most influential and effective cancer surveillance and epidemiology programs in the world. Under Dr Eyre's stewardship, the Cancer Prevention Study 3 (CPS-3) launched in 2006. The CPS-3 cohort was designed to help the ACS understand the differences between people who get cancer and people who don’t get cancer by utilizing participant recruitment strategy to achieve greater racial and ethnic diversity and collecting biospecimens for molecular epidemiology research. It continues to provide insights into the causes of cancer today and is likely to continue to bear fruit well into the 2030s. Dr Eyre was instrumental in ensuring continuous support in the pursuit of cancer-related research. For example, in response to federal reductions in funding of grants available to early career investigators in the 1990s, he effectively convinced the ACS board to shift the ACS research program's emphasis with greater support for such researchers. In addition, he led the ACS’s efforts to sponsor tobacco-control grants at a time when federal sponsorship was waning. Dr Eyre also contributed to several ACS guidelines on cancer screening and prevention. For example, he led the ground-breaking prostate cancer screening process, which followed the ACS's organization of a review of the scientific literature and a gathering of external experts in the areas of both screening and treatment for prostate cancer. The ultimate recommendation called for informed decision making between the patient and the physician. It acknowledged the legitimate concerns about over-screening and overtreatment of the disease but also the hope that prostate cancer screening might save lives. Although released in 1997, it remains highly relevant today and serves as the basis for contemporary prostate cancer screening guidelines and statements from numerous organizations in the United States, Canada, and Europe. Other ACS guidelines implemented under Dr Eyre include the colorectal screening guideline, which added screening colonoscopy, and the 2002 cervical cancer screening guideline, which added human papillomavirus DNA testing. Dr Eyre went on to write a book entitled Informed Decisions. Together with his work in guidelines, it continues to influence many of today's cancer screening guidelines, including those related to lung cancer and the evolving field in multicancer early detection testing. Born and raised in Utah by his parents, who were both schoolteachers, Dr Eyre was one of six children. He graduated from Utah State University in 1962 and medical school at the University of Utah in 1966 before completing the Osler Internal Medicine Residency at Johns Hopkins University. He completed a fellowship in medical oncology at the National Cancer Institute in 1970 and, in the same year, joined the faculty of the University of Utah School of Medicine, where he went on to serve as associate chairman of Internal Medicine and deputy director of the Huntsman Cancer Institute. Harmon Eyre was a compassionate man with integrity, common sense, and a deep understanding of science and medicine. Dr Harmon was married to Julie Sears Eyre for more than 66 years and, together, they continued to support and contribute to the mission of the ACS long after his tenure as Chief Medical Officer through the active support of ACS initiatives and its staff. He and his wife are beloved friends and role models to many, and the ACS was fortunate to have Dr Harmon as a leader. May he rest in peace.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction distillée sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.

score de la tête « metaresearch » (Codex)0,000
score de la tête « metaresearch » (Gemma)0,000
Version: codex-gemma-dda1882f352aStatut de validation: machine_predicted_unvalidated
Catégories candidatesCharge utile insuffisante (le modèle a refusé de juger)
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Sans objet · Signal consensuel: Sans objet
GenreSignal candidat: Autre · Signal consensuel: Autre
Score de désaccord entre enseignants0,141
Score d'incertitude au seuil0,994

Scores Codex et Gemma par catégorie

CatégorieCodexGemma
Métarecherche0,0000,000
Méta-épidémiologie (sens strict)0,0000,000
Méta-épidémiologie (sens large)0,0000,000
Bibliométrie0,0000,000
Études des sciences et des technologies0,0010,000
Communication savante0,0000,000
Science ouverte0,0000,000
Intégrité de la recherche0,0000,000
Charge utile insuffisante (le modèle a refusé de juger)0,0070,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,129
Tête enseignante GPT0,396
Écart entre enseignants0,267 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.

Devis d'étudeSans objet
Domainenon disponible
GenreAutre

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations0
Publié2025
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueCA A Cancer Journal for CliniciansMême sujetMedical History and InnovationsTravaux en français237 207